May 29, 2023 – The head of regulatory affairs at Proxima Clinical Research, RAC, Isabella Schmitt, writes in MED-TECH Innovation magazine on the potential difficulties and procedures that must be considered while developing an AI-integrated medical device.
Artificial intelligence is becoming increasingly important in today’s world and is always more prominent in the medical world. When you want to develop a tool with the idea of improving and revolutionizing not only patient care but, like in the case of the AISym4MED project, the work of researchers and practitioners – just to name a few – you need to consider several technical and ethical aspects.
In her article, Isabel Schmitt specifically reflects on the importance of the following steps: development, i.e., reflecting on the right algorithms to be considered, a choice that must be very thoughtful, considering the different information and specific tasks, selection of high-quality data, assessment of the accuracy of the model through specific tests, and validation of the data in relation to the real-world data. Finally, study the different regulations existing in different countries in the fields of Artificial Intelligence and the General Data Protection Regulation (GDPR), an issue that is becoming progressively more relevant at the European level and beyond.
In this regard, bearing in mind all the previous steps and much more, the AISym4Med project seeks to create a platform that gives healthcare data engineers, practitioners, and academics access to a reliable dataset system enhanced with controlled data synthesis for experimental and modeling needs. This platform will handle data security and privacy by fusing innovative anonymization methods, reliable tracking systems, and attribute-based privacy protections.
Read more about the AISym4MED project: HERE
Read more about the article “Creating an AI-Integrated medical device in Today’s world”, on MED-TECH Innovation magazine: HERE
